FDA Approved: PAMIDRONATE DISODIUM — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira's supplemental application for pamidronate disodium, confirming the regulatory approval for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia of Malignancy
• Osteoporosis
• Paget Disease of Bone

Drugs mentioned

• Pamidronate disodium (Pamidronate disodium)

Snippet

SUPPL AP for PAMIDRONATE DISODIUM (PAMIDRONATE DISODIUM)